CORT Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:51):
Our systems believe the stock currently is undervalued by 0.08% compare to its pairs and should correct upwards.

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States...

Stats
Dagens volum	458 759
Gjennomsnittsvolum	1.16M
Markedsverdi	3.27B
EPS	$0.270 ( Q1 \| 2024-05-01 )
Neste inntjeningsdato	( $0 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	29.91 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0330 (0.11%)

AADI -5.88%

ABCL 0.73%

ABCM 0.04%

ABEO -3.08%

ABIO -0.30%

ABOS 2.57%

ABSI 3.23%

ABUS -0.98%

ABVX -3.00%

ACAD -0.35%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 1.93%

ACIU -0.75%

ACLX -0.37%

ACRV -4.30%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -4.00%

ADGI 0.87%

ADIL -2.66%

ADMA -1.23%

ADPT 0.44%

ADTX -3.47%

ADVM 1.52%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -3.06%

AGEN -3.97%

AGIO -2.51%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.21%

AKRO -2.34%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -0.80%

ALGS -3.03%

ALKS 1.92%

ALLK -11.39%

ALLO -2.08%

ALLR -1.63%

ALNA 3.16%

ALNY 2.37%

ALPN 0.02%

ALPX 0.00%

ALRN -2.62%

ALT -15.25%

ALVR -0.76%

ALXN 0.00%

ALXO -10.35%

ALZN 5.10%

AMRN -4.28%

AMTI -3.13%

ANAB 1.51%

ANEB 7.95%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 3.93%

ANPC -3.15%

APGE 2.03%

APGN 8.48%

APGNW 30.65%

APLM -5.86%

APLS 0.40%

APLT 1.13%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 0.38%

ARAV -13.39%

ARCT -6.70%

ARDS -12.13%

ARDX 2.16%

ARGX -0.67%

ARNA 0.00%

ARPO -0.90%

ARQT -2.97%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.62%

ARWR -2.42%

ASLN -5.07%

ASMB -5.55%

ASND -2.25%

ATAI -3.69%

ATHA 7.76%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 5.37%

ATRA -5.66%

ATXI 1.09%

ATXS -0.44%

AUPH -0.90%

AURA 4.55%

AUTL -3.16%

AVBP -2.15%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE 0.00%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -1.30%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.18%

BCAB -6.89%

BCDA -0.85%

BCDAW -46.41%

BCEL 0.00%

BCLI 3.09%

BCRX 1.56%

BCTX 13.26%

BCTXW 13.02%

BCYC 0.90%

BDRX -5.56%

BDTX 0.11%

BEAM 2.72%

BFRA -2.91%

BGNE -2.93%

BIOR -3.83%

BIVI 1.71%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -1.76%

BLTE -1.25%

BLU 0.03%

BLUE -4.88%

BMEA -15.16%

BMRN 0.20%

BNOX 4.46%

BNTC -2.39%

BNTX -2.14%

BOLD -11.17%

BOLT -0.19%

BPMC -2.17%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -6.60%

BTAI 13.56%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.78%

CABA 1.11%

CADL 1.43%

CALA 0.00%

CALC -3.82%

CALT -1.59%

CAPR -0.11%

CARA -11.78%

CARM 6.52%

CASI -1.18%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.67%

CCCC -1.70%

CCXI 0.00%

CDAK 0.00%

CDIO -2.99%

CDIOW 24.00%

CDMO -1.62%

CDMOP 0.04%

CDT -6.02%

CDTTW -39.60%

CDTX -6.28%

CDXC 10.04%

CDXS 9.48%

CELC -3.39%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.48%

CERO -4.94%

CEROW -10.18%

CFRX -27.95%

CGEM 0.24%

CGEN -3.32%

CGON -2.64%

CGTX -3.43%

CHMA -6.00%

CHRS 4.42%

CINC 0.00%

CING -3.75%

CINGW 34.95%

CKPT -1.20%

CLBS -16.75%

CLDX -0.57%

CLGN -0.40%

CLLS -3.11%

CLNN -2.49%

CLNNW 0.00%

CLRB 6.47%

CLSD -3.34%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.23%

CMPI 0.00%

CMPX 1.89%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -34.50%

CNST 0.00%

CNTA 0.79%

CNTB -1.50%

CNTX -7.53%

COCP -1.83%

COEPW 32.45%

COGT -2.76%

CORT 3.36%

COYA -2.42%

CPRX -1.25%

CRBP -1.69%

CRBU -7.95%

CRDF 2.22%

CRGX -1.54%

CRIS -2.64%

CRNX -5.79%

CRSP 1.25%

CRTX 2.63%

CRVO -4.50%

CRVS 0.00%

CSBR -0.19%

CTCX 1.20%

CTIC 0.06%

CTMX -3.72%

CTNM 4.72%

CTXR -4.48%

CUE -2.78%

CVAC -5.08%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 20.75%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.76%

CYTO 0.00%

DARE 0.86%

DAWN -0.07%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 31.86%

DNLI -1.88%

DNTH -2.54%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.42%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -2.92%

EDSA 4.14%

EFTR 1.50%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.17%

ELEV -1.45%

ELOX 10.77%

ELTX -3.38%

ELVN -1.30%

ELYM 5.45%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -1.06%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.87%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 6.25%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -5.92%

ETON 2.59%

ETTX 0.00%

EVAX 0.00%

EVGN 3.46%

EVLO 0.00%

EWTX 0.23%

EXAI -0.38%

EXEL 0.83%

EYEG -0.69%

EYEN 0.00%

EYPT 0.00%

FATE -12.23%

FBIO 0.90%

FBIOP 0.87%

FBLG -10.30%

FBRX -0.04%

FDMT -4.59%

FENC -2.73%

FGEN -9.87%

FHTX 8.64%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.67%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.58%

FULC 2.26%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -1.53%

GBIO -1.06%

GBT 0.01%

GDTC 0.50%

GERN -1.66%

GHRS -4.27%

GLMD -2.50%

GLPG -1.76%

GLSI 9.27%

GLTO -3.90%

GLUE -2.51%

GLYC -14.97%

GMAB -0.37%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.00%

GNPX -4.41%

GNTA 3.94%

GOSS -7.75%

GOVX -5.45%

GOVXW 10.89%

GPCR -6.16%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.16%

GRTX -1.66%

GTHX 2.50%

GUTS -0.23%

GXGXW 41.67%

GYRE -5.95%

HALO -1.01%

HARP 0.09%

HCWB -10.05%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -0.54%

HOOK 1.41%

HOTH -3.67%

HOWL 0.21%

HRMY 3.06%

HRTX 8.36%

HSTO 0.00%

HUMA 1.95%

HUMAW -6.25%

IBRX -6.60%

ICCC -2.10%

ICPT 0.21%

ICU 19.73%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.20%

IFRX -3.22%

IGMS -2.12%

IKNA -1.79%

IKT -2.08%

IMAB -0.58%

IMCR -3.50%

IMGN 0.02%

IMGO 0.00%

IMMP 5.51%

IMMX -6.03%

IMNM 3.81%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.71%

IMTX -1.17%

IMTXW 6.00%

IMUX -4.63%

IMV 0.00%

IMVT -3.77%

INAB -1.12%

INBX -3.18%

INCY -2.08%

INDP 6.88%

INFI -52.38%

INKT 0.00%

INM 3.06%

INMB 1.54%

INO 2.02%

INSM -0.85%

INTS -3.73%

INVA 0.74%

INZY 1.14%

IOBT -7.11%

IONS 1.62%

IOVA -3.96%

IPA 0.03%

IPHA 2.54%

IPSC -2.73%

IRON -1.95%

ISEE 0.38%

ITOS 2.87%

ITRM 1.51%

IVA 6.96%

IVVD 0.00%

JAGX 0.79%

JANX -5.40%

JAZZ -0.92%

JNCE 0.00%

JSPR -1.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.47%

KALV -2.46%

KDNY 0.22%

KMPH -0.34%

KNSA -2.42%

KNTE -0.38%

KOD -8.70%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.33%

KRRO -1.59%

KRTX 0.03%

KRYS 1.02%

KTRA 9.82%

KTTA -0.65%

KTTAW 0.92%

KURA 0.93%

KYMR -3.50%

KYTX -5.23%

KZIA 7.51%

KZR -1.75%

LABP 0.57%

LBPH 0.59%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.54%

LENZ -3.21%

LEXX 0.58%

LEXXW -14.63%

LGND -0.82%

LGNDV 0.00%

LGVN -8.52%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.35%

LPCN -4.36%

LPTX -1.65%

LQDA 0.40%

LRMR -0.43%

LSTA -1.68%

LTRN 5.49%

LUMO 0.67%

LVTX -4.64%

LXEO -13.57%

LXRX -1.18%

LYEL -36.12%

LYRA 4.22%

MACK 0.10%

MBIO -11.76%

MBRX -1.43%

MCRB 1.25%

MDGL -1.84%

MDNA -13.16%

MDWD 3.18%

MDXG -1.69%

MEIP 0.70%

MESO -1.26%

MGNX -5.24%

MGTA -7.74%

MGTX -0.95%

MGX -0.54%

MIRM -0.57%

MIRO 0.59%

MIST 1.92%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.88%

MLYS -8.46%

MNKD -0.67%

MNMD 2.90%

MNOV 1.41%

MNPR -8.52%

MOLN 0.76%

MOR 0.62%

MORF -2.89%

MREO 0.00%

MRKR -0.43%

MRNA -10.82%

MRNS -6.62%

MRSN -3.81%

MRTX -0.17%

MRUS 0.70%

MRVI 1.24%

MTCR -1.29%

MTEM 7.43%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS -0.10%

NAMSW 0.64%

NAUT 0.23%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.89%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.87%

NKTX -2.69%

NLSP 4.91%

NLSPW 26.67%

NMRA -1.37%

NMTR -42.97%

NOVN -24.84%

NRBO 15.13%

NRIX -1.54%

NRSN 0.78%

NRSNW 0.00%

NRXP -8.92%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.63%

NTRBW -31.07%

NUVL -1.84%

NVAX -5.57%

NVCT -8.39%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 3.03%

OABIW -10.06%

OBIO 0.04%

OBSV 0.00%

OCEA -4.23%

OCGN 7.20%

OCS -1.00%

OCUL 0.23%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.60%

OMER -2.44%

OMGA -2.08%

ONCO 6.37%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 1.98%

ONTX -0.47%

ONVO 1.97%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -3.41%

ORMP 16.33%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.28%

OVID 0.70%

OYST 0.00%

PALI -0.48%

PASG 0.00%

PBLA -7.50%

PBM -4.75%

PBYI 4.56%

PCSA 0.00%

PCVX 0.60%

PDSB -5.38%

PEPG 1.37%

PGEN -6.89%

PHAR 1.99%

PHAS 0.00%

PHAT 0.53%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.50%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.56%

PLUR 10.34%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT -3.19%

PRAX 4.97%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 1.57%

PRQR 1.20%

PRTA -3.32%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.26%

PTCT -0.03%

PTE -0.82%

PTGX 1.13%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.84%

QNCX 2.23%

QNRX 0.87%

QSI -28.62%

QSIAW -9.44%

QTTB 3.95%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -1.63%

RARE 1.66%

RCKT -10.11%

REGN -0.21%

RENB -3.42%

REPL -2.66%

RETA 0.02%

REUN -0.89%

REVB -1.86%

REVBU 3.46%

REVBW 5.00%

RGLS -5.84%

RGNX -6.53%

RIGL -6.24%

RLAY -5.64%

RLMD -0.33%

RLYB -5.37%

RNA 2.18%

RNAC -1.62%

RNAZ -1.92%

RNXT 2.23%

ROIV -2.08%

ROIVW 4.56%

RPHM -2.48%

RPRX -0.80%

RPTX -1.17%

RUBY 2.70%

RVLP -32.05%

RVMD -0.24%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.18%

RYTM -5.89%

RYZB 0.02%

RZLT 3.10%

SABS -1.37%

SABSW -5.53%

SAGE -0.37%

SANA -2.03%

SAVA -4.23%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 1.29%

SCPH 11.62%

SCPS 0.00%

SEEL -3.18%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.55%

SGMT -5.06%

SGTX -2.56%

SIOX 22.63%

SLDB -2.33%

SLGL 5.23%

SLN -8.77%

SLNO 0.64%

SLRX 0.40%

SLS -3.85%

SMMT -3.37%

SNDX 2.00%

SNGX 3.40%

SNPX -2.76%

SONN 0.53%

SPPI -0.49%

SPRB -1.68%

SPRC -3.29%

SPRO 0.38%

SRNE 0.00%

SRPT -0.75%

SRRA 0.00%

SRRK -1.24%

SRZN -2.45%

STAB 0.00%

STOK -6.93%

STRO -2.84%

STSA 0.00%

STTK 7.04%

SURF -0.93%

SVRA -4.08%

SWTX -0.16%

SYBX 0.00%

SYRS -2.07%

TALS -0.73%

TARA -7.66%

TARS -2.44%

TBPH 0.18%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.48%

TCRX -2.26%

TECH -1.35%

TENX -0.32%

TERN -6.76%

TFFP -11.17%

TGTX -8.13%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.65%

TNGX -3.78%

TNXP -9.64%

TNYA -6.13%

TPST 5.35%

TRDA -4.71%

TRVI 1.92%

TRVN 3.15%

TSHA -17.89%

TSVT -4.20%

TTNP -6.05%

TVTX 3.83%

TYRA -7.66%

UBX -2.73%

UNCY -4.00%

URGN 3.70%

UTHR -0.42%

VACC 11.36%

VALN -3.15%

VAXX 118.75%

VBIV -0.79%

VBLT -8.77%

VCEL 1.51%

VCNX 9.30%

VCYT -0.97%

VERA -4.56%

VERU 1.32%

VERV -3.54%

VIGL 1.61%

VINC 2.81%

VIR -1.14%

VIRI -5.66%

VIRX 3.45%

VKTX -1.15%

VLON -13.04%

VNDA -2.94%

VOR -6.03%

VRCA 1.70%

VRDN -3.29%

VRNA -2.00%

VRPX 3.58%

VRTX -0.14%

VSTM 4.59%

VTGN -2.41%

VTVT 1.28%

VTYX -1.88%

VXRT -0.39%

VYGR -0.70%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.07%

XBIO 1.03%

XBIT 5.00%

XCUR 0.23%

XENE -0.88%

XERS 4.75%

XFOR 5.21%

XLO 3.06%

XLRN 0.00%

XNCR 0.13%

XOMA -7.04%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-24	Robb Gary Charles	Sell	2 650	Common Stock
2024-06-24	Robb Gary Charles	Buy	550	Common Stock
2024-06-24	Robb Gary Charles	Buy	550	Common Stock
2024-06-24	Robb Gary Charles	Sell	1 000	Common Stock
2024-06-04	Robb Gary Charles	Buy	14 000	Common Stock

INSIDER POWER
8.36
Last 100 transactions
Buy: 601 490 \| Sell: 515 800

Korrelasjon (AI algo v.1.1b): Undervalued: 0.08% $31.45 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.34 (neutral)

Kort: 0.86 (strong)

Signal:(64.844) Same movement expected

Corcept Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
OZEM	1
NUVOW	0.858
MINDP	0.856
CXSE	0.838
CGNX	0.835
JD	0.829
IGF	0.825
LDEM	0.824
MCHI	0.82
SOCL	0.808

10 Mest negative korrelasjoner
GECCI	-0.803

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Corcept Therapeutics Inc Korrelasjon - Valuta/Råvare

0.00
( neutral )

Corcept Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$482.38M
Bruttogevinst:	$475.89M (98.66 %)
EPS:	$1.020

FY	2023
Omsetning:	$482.38M
Bruttogevinst:	$475.89M (98.66 %)
EPS:	$1.020

FY	2022
Omsetning:	$401.86M
Bruttogevinst:	$396.47M (98.66 %)
EPS:	$0.950

FY	2021
Omsetning:	$365.98M
Bruttogevinst:	$360.70M (98.56 %)
EPS:	$0.970

Financial Reports:

No articles found.

Corcept Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Corcept Therapeutics Inc

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.